Feasibility of a 4-Week Intensive Postoperative Multimodal Rehabilitation Program in Complicated Patients After Proximal Pancreatectomy: A Prospective Single-Cohort Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIRCCS San Raffaele

About this trial

The REACT study is a prospective, single-center, single-cohort study designed to evaluate the feasibility of a 4-week intensive multimodal postoperative rehabilitation program in patients who develop severe complications after proximal pancreatic resection (pancreatoduodenectomy or total pancreatectomy).

Postoperative complications after pancreatic surgery may result in substantial physiological and metabolic stress, leading to loss of muscle mass, malnutrition, reduced functional capacity, and delayed recovery. Although prehabilitation programs have been proposed to improve patients' functional capacity before surgery, evidence regarding structured multimodal rehabilitation after pancreatic surgery is currently lacking.

Adult patients undergoing elective proximal pancreatic resection who develop a severe postoperative complication (Comprehensive Complication Index \>21) will be eligible for the study. Participants will undergo a 4-week multimodal rehabilitation program starting after hospital discharge and including individualized exercise training, nutritional therapy, and anxiety-reducing techniques. The program may be delivered either in a supervised hospital-based setting or through a home-based program according to patient preference and availability.

The primary objective is to assess the feasibility of the rehabilitation program in terms of recruitment, adherence, completion of outcome assessments, completeness of data, and safety. Secondary objectives include evaluating postoperative functional recovery using PROMIS-29 Physical and Mental Health Summary Scores, the 6-minute walk test, and the Duke Activity Status Index. In patients with malignancy who are candidates for adjuvant treatment, return to intended oncologic treatment will also be evaluated.

A total of 40 patients will be enrolled and followed for up to 90 days after surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years.

Patients undergoing elective proximal pancreatic resection (pancreatoduodenectomy or total pancreatectomy).

Patients developing a severe postoperative complication during their hospital stay, defined as a Comprehensive Complication Index (CCI) >21.

Disqualifiers

Metastatic disease.

Surgical procedures other than pancreatoduodenectomy or total pancreatectomy.

Inability to speak Italian.

Cognitive impairment or illiteracy resulting in inability to read and understand the Italian language.

Trial design

Design model

Single group

Treatments tested in this trial

  • Multimodal Postoperative Rehabilitation Program

    Behavioral

    Participants will undergo a 4-week multimodal postoperative rehabilitation program starting during the first week after hospital discharge. The program includes individualized exercise training, nutritional therapy, and anxiety-reducing techniques. Exercise includes moderate-intensity endurance, resistance, and breathing exercises tailored to the patient's clinical condition and may be delivered in a hospital-based or home-based setting. Nutritional therapy consists of an individualized dietary plan, with a recommended protein intake of 1.5-2.0 g/kg of ideal body weight and whey protein supplementation if needed. Participants will also receive instruction in relaxation techniques, including imagery, visualization, and deep-breathing exercises. The program is delivered by qualified physiotherapists, nutritionists, and psychology-trained personnel.

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: Multimodal Postoperative RehabilitationExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility of the multimodal postoperative rehabilitation program

Feasibility will be assessed according to five predefined criteria: 1. ≥50% of eligible patients agree to participate; 2. ≥80% of enrolled patients adhere to the program; 3. ≥80% complete the post-rehabilitation outcome assessment; 4. missing data among patients completing outcome assessments are \<10%; (5) no serious adverse events related to the rehabilitation program occur. The intervention will be considered feasible only if all five criteria are met.

Time frame
At the end of the 4-week rehabilitation program

Secondary outcomes

1

PROMIS-29 Physical Health Summary Score recovery

Proportion of participants who recover their preoperative PROMIS-29 Physical Health Summary Score (PHS) or show a decline smaller than the minimal important difference (MID) of 2.3 points.

Time frame
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
2

PROMIS-29 Mental Health Summary Score recovery

Proportion of participants who recover their preoperative PROMIS-29 Mental Health Summary Score (MHS) or show a decline smaller than the minimal important difference (MID) of 2.3 points.

Time frame
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
3

Six-Minute Walk Test recovery

Proportion of participants who recover their preoperative 6-minute walk test (6MWT) performance or show a decline smaller than the minimal important difference of 19 meters.

Time frame
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
4

Duke Activity Status Index recovery

Proportion of participants who recover their preoperative Duke Activity Status Index (DASI) or show a decline smaller than the minimal important difference of 6 METs.

Time frame
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.